Full name
NOVETION SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.11.Z - Research and experimental development on biotechnology
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale | 28 | -40,3 | -243,8 | |
Gross profit (loss) | -16,2 | 260,6 | 33,4 | -87,2 |
EBITDA | -16 | 262,4 | 47,8 | -81,8 |
Short time liabilities | 0,6 | 2,4 | 51,7 | 2019,1 |
Other operating costs | 0 | 0,5 | 5752,5 | |
Equity capital | -88,1 | 154,2 | 187,6 | 21,7 |
Operating profit (EBIT) | -16 | 262,4 | 47,8 | -81,8 |
Assets | 74,8 | 156,6 | 364,9 | 133 |
Net profit (loss) | -16,2 | 242,3 | 33,4 | -86,2 |
Cash | 36 | 77,8 | 0,3 | -99,6 |
Liabilities and provisions for liabilities | 162,9 | 2,4 | 177,4 | 7175,9 |
Net income from sale | 0,1 | 182,5 | 88,1 | -51,7 |
Working assets | 74,8 | 156,6 | 364,9 | 133 |
Other income costs | 234,4 | 88,6 | -62,2 | |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 18,4 | 157,1 | 17,8 | -139,3 |
Equity capital to total assets | -117,7 | 98,4 | 51,4 | -47 |
Gross profit margin | -29 165,9 | 142,8 | 37,9 | -104,9 |
EBITDA Margin | -28 787,5 | 143,8 | 54,3 | -89,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 3634 | 5 | 214 | 209 |
Current financial liquidity indicator | 0.4593004286289215 | 64.24050903320312 | 7.064180374145508 | -57,1 |
Net dept to EBITDA | 2.256148338317871 | -0.2964872717857361 | 2.917015790939331 | 3,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane